Home
Philosophy
Portfolio
Team
Scientific Advisory Board
Ray Dolby’s Legacy
News
Contact
Envisagenics Raises Series B to Fuel AI-Enabled Novel Therapeutic Pipeline
Comments are closed.
Envisagenics Raises Series B to Fuel AI-Enabled Novel Therapeutic Pipeline
System1 Announces $25 Million Series A Funding
Tempo Automation completes SPAC transaction and begins trading on NASDAQ under ticker TMPO
Virtual Power Systems Raises $17 Million in Growth Capital Led by CUI Global
